Bulletin

Press Information Bureau

Dr. Mansukh Mandaviya launches ICMR/ DHR Policy on Biomedical Innovation & Entrepreneurship for Medical Professionals, Scientists and Technologists at Medical, Dental, Para-Medical Institutes/Colleges

February 24, 2025

Roche

FDA approves Xolair as first and only medicine for children and adults with one or more food allergies

February 16, 2025

Press Information Bureau

Union Health Ministry organises “Cycle for Health” rally at Lady Hardinge Medical College

February 14, 2025

Press Information Bureau

Update on India's Progress in Malaria Elimination

December 25, 2024

WHO

Yemen reports the highest burden of cholera globally

December 23, 2024

Press Information Bureau

President of India Addresses 6th Convocation of Vardhman Mahavir Medical College and Safdarjung Hospital

December 23, 2024

Press Information Bureau

Union Health Minister Shri JP Nadda holds meeting with Chief Ministers on the 100-day Intensified TB Elimination Campaign

December 21, 2024

WHO

Lebanon: soaring needs for trauma treatment and rehabilitation

December 20, 2024

Roche

FDA grants priority review to Xolair (omalizumab) for children and adults with food allergies based on positive National Institutes of Health phase III study results

December 19, 2024

Press Information Bureau

Union Health Ministry sensitizes Members of Parliament from Lok Sabha and Rajya Sabha on the 100-day Intensified TB Elimination Campaign

December 18, 2024

WHO

Multi-country outbreak of cholera, External situation report #21

December 18, 2024

Press Information Bureau

Update on National Health Mission

December 17, 2024

Press Information Bureau

Production Linked Incentive Scheme for Promoting Domestic Manufacturing of Medical Devices to promote indigenous manufacturing of medical devices

December 17, 2024

Press Information Bureau

Update on Ayushman Bharat Digital Mission

December 17, 2024

Press Information Bureau

India’s pharmaceutical market for FY 2023-24 is valued at USD 50 billion with domestic consumption valued at USD 23.5 billion and export valued at USD 26.5 billion

December 17, 2024

Roche

Roche receives CE Mark for new and updated molecular cobas 6800/8800 systems, enhancing laboratory efficiency and testing capabilities

December 13, 2024

< 1 … 18 19 20 21 22 23 24 25 26 … 94 >

Bulletin

Dr. Mansukh Mandaviya launches ICMR/ DHR Policy on Biomedical Innovation & Entrepreneurship for Medical Professionals, Scientists and Technologists at Medical, Dental, Para-Medical Institutes/Colleges

FDA approves Xolair as first and only medicine for children and adults with one or more food allergies

Union Health Ministry organises “Cycle for Health” rally at Lady Hardinge Medical College

Update on India's Progress in Malaria Elimination

Yemen reports the highest burden of cholera globally

President of India Addresses 6th Convocation of Vardhman Mahavir Medical College and Safdarjung Hospital

Union Health Minister Shri JP Nadda holds meeting with Chief Ministers on the 100-day Intensified TB Elimination Campaign

Lebanon: soaring needs for trauma treatment and rehabilitation

FDA grants priority review to Xolair (omalizumab) for children and adults with food allergies based on positive National Institutes of Health phase III study results

Union Health Ministry sensitizes Members of Parliament from Lok Sabha and Rajya Sabha on the 100-day Intensified TB Elimination Campaign

Multi-country outbreak of cholera, External situation report #21

Update on National Health Mission

Production Linked Incentive Scheme for Promoting Domestic Manufacturing of Medical Devices to promote indigenous manufacturing of medical devices

Update on Ayushman Bharat Digital Mission

India’s pharmaceutical market for FY 2023-24 is valued at USD 50 billion with domestic consumption valued at USD 23.5 billion and export valued at USD 26.5 billion

Roche receives CE Mark for new and updated molecular cobas 6800/8800 systems, enhancing laboratory efficiency and testing capabilities

Company

Resources